Culture Biosciences
Private Company
Total funding raised: $98.5M
Overview
Culture Biosciences is a private technology and services company founded in 2016 and headquartered in South San Francisco, California. It operates at the intersection of bioprocessing and digital technology, offering a suite of cloud-connected bioreactors and software designed to streamline and accelerate bioprocess development for biologics. The company's model is primarily service and platform-based, providing tools and lab services to biopharma companies, thereby generating early revenue. Its collaboration with industry leader Cytiva highlights its strategic positioning to modernize biomanufacturing workflows.
Technology Platform
Integrated platform of cloud-connected single-use bioreactors (Stratyx), cloud-native experiment management & analytics software (Console), and bioprocessing development services (Nexxys). Designed to generate structured data for AI/ML-driven bioprocess optimization.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Culture competes with established bioreactor and bioprocess equipment vendors (e.g., Sartorius, Thermo Fisher Scientific, Cytiva itself) who are integrating software into their hardware. It also competes with contract development and manufacturing organizations (CDMOs) offering process development services and with emerging digital bioprocessing software startups. Its key differentiation is the tight, native integration of its own hardware, software, and services into a single data-generating platform.